Ledger.Open graph →
SEC Form D · filed October 8, 2025

Rinascera Therapeutics, Inc

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Nichola Eliovits · San Jose, CAExec · DirectorMax Dawson · BOSTON, MAExecDaniel Yadegar · BOSTON, MADirectorKarl Beutner · BOSTON, MAExec · DirectorNichola Eliovits · San Jose, CAExec · DirectorMax Dawson · BOSTON, MAExecDaniel Yadegar · BOSTON, MADirectorKarl Beutner · BOSTON, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗